Lymphangiogenesis in development and human disease

被引：969

作者：

Alitalo, K

Tammela, T

Petrova, TV

机构：

[1] Univ Helsinki, Ludwig Inst Canc Res, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland

[2] Univ Helsinki, Biomedicum Helsinki, Mol Cell Biol Program, Haartman Inst, FIN-00014 Helsinki, Finland

[3] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland

来源：

NATURE | 2005年 / 438卷 / 7070期

基金：

芬兰科学院; 美国国家卫生研究院;

关键词：

D O I：

10.1038/nature04480

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The lymphatic vasculature forms a vessel network that drains interstitial fluid from tissues and returns it to the blood. Lymphatic vessels are also an essential part of the body's immune defence. They have an important role in the pathogenesis of several diseases, such as cancer, lymphoedema and various inflammatory conditions. Recent biological and technological developments in lymphatic vascular biology will lead to a better understanding and treatment of these diseases.

引用

页码：946 / 953

页数：8

共 100 条

[1] Chylous ascites: A collective review
Aalami, OO
Allen, DB
Organ, CH
[J]. SURGERY, 2000, 128 (05) : 761 - 778
[2] Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk
Abtahian, F
Guerriero, A
Sebzda, E
Lu, MM
Zhou, R
Mocsai, A
Myers, EE
Huang, B
Jackson, DG
Ferrari, VA
Tybulewicz, V
Lowell, CA
Lepore, JJ
Koretzky, GA
Kahn, ML
[J]. SCIENCE, 2003, 299 (5604) : 247 - 251
[3] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
Achen, MG
Jeltsch, M
Kukk, E
Mäkinen, T
Vitali, A
Wilks, AF
Alitalo, K
Stacker, SA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
[4] Eph receptors and ephrin ligands: Essential mediators of vascular development
Adams, RH
Klein, R
[J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (05) : 183 - 188
[5] Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1
Ayadi, A
Zheng, H
Sobieszczuk, P
Buchwalter, G
Moerman, P
Alitalo, K
Wasylyk, B
[J]. EMBO JOURNAL, 2001, 20 (18) : 5139 - 5152
[6] Vascular endothelial growth factor d is dispensable for development of the lymphatic system
Baldwin, ME
Halford, MA
Roufail, S
Williams, RA
Hibbs, ML
Grail, D
Kubo, H
Stacker, SA
Achen, MG
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) : 2441 - 2449
[7] Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
Baluk, P
Tammela, T
Ator, E
Lyubynska, N
Achen, MG
Hicklin, DJ
Jeltsch, M
Petrova, TV
Pytowski, B
Stacker, SA
Ylä-Herttuala, S
Jackson, DG
Alitalo, K
McDonald, DM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) : 247 - 257
[8] Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24
Brice, G
Mansour, S
Bell, R
Collin, JR
Child, AH
Brady, AF
Sarfarazi, M
Burnand, KG
Jeffery, S
Mortimer, P
Murday, VA
[J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (07) : 478 - 483
[9] PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis
Cao, RH
Björndahl, MA
Religa, P
Clasper, S
Garvin, S
Galter, D
Meister, B
Ikomi, F
Tritsaris, K
Dissing, S
Ohhashi, T
Jackson, DG
Cao, YH
[J]. CANCER CELL, 2004, 6 (04) : 333 - 345
[10] Vascular endothelial growth factor C induces angiogenesis in vivo
Cao, YH
Linden, P
Farnebo, J
Cao, RH
Eriksson, A
Kumar, V
Qi, JH
Claesson-Welsh, L
Alitalo, K
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) : 14389 - 14394

← 1 2 3 4 5 6 7 8 9 10 →